Home » Topics » BioWorld Science

BioWorld Science
RSS

Omigapil completes first clinical trial in patients with congenital muscular dystrophy

April 5, 2018

BB100 licenses MAbs targeting E. coli from Arsanis

April 5, 2018

Boehringer Ingelheim and OSE sign collaboration and license agreement for OSE-172

April 5, 2018

Q-State Biosciences enters drug discovery collaboration with Vertex

April 5, 2018

PLA2-R is a potential diagnostic marker of salivary gland tumors

April 5, 2018

Roche acquires Inception neuroscience program from Versant Ventures

April 5, 2018

Phase III REACH-2 study of Cyramza meets primary endpoint

April 5, 2018

FDA and EMA accept regulatory submissions for dacomitinib

April 5, 2018

Novel orally bioavailable rohitukine derivative shows promise in xenograft cancer models

April 5, 2018

Triple combination program for the treatment of cystic fibrosis receives FDA fast track designation

April 5, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...